Merck Has Strong Results in a Cancer Drug Trial
Monday, June 3, 2013 - 16:20
in Health & Medicine
The drug, lambrolizumab, significantly shrank melanoma tumors, the company reported on Sunday.
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via